在社区肺癌CT筛查中增加腹部平扫CT筛查肾癌及其他腹部病变:约克郡肾脏筛查试验结果
约克郡肾脏筛查试验(YKST)前瞻性评估在肺癌筛查中增加腹部平扫CT(NCCT)筛查肾癌及其他腹部病变的可行性。2021年5月至2022年10月,55-80岁既往吸烟者接受腹部NCCT,4019人(93%)接受检查,5.3%发现新的严重病变,0.25%经组织学确诊肾癌。筛查发现一例严重腹部病变需筛查18人,发现一例疑似肾脏病变需93人,发现一例组织学确诊肾癌需402人。
要点
- 在肺癌CT筛查中增加腹部NCCT可行,93%的符合条件者接受检查,仅3.9%对参与表示后悔。
- 5.3%的参与者发现新的严重病变,包括0.62%的肾脏肿块/复杂囊肿和1.5%的腹主动脉瘤(AAA)。
- 发现一例严重腹部病变需筛查18人,发现一例组织学确诊肾癌需筛查402人。
核心结论
- 在这项首次前瞻性风险分层筛查研究中,与胸部CT同时提供腹部NCCT的接受度和参与者满意度均高。
- 严重病变、癌症和腹主动脉瘤的患病率与结直肠癌等已建立的筛查项目相当。
- 现在应评估长期结局和成本效益。
研究设计与样本
- 前瞻性诊断研究,纳入55-80岁既往吸烟者,于2021年5月至2022年10月在英国一项随机肺癌筛查试验中接受腹部NCCT。
- 排除标准为痴呆、衰弱、既往肾癌/肺癌、既往6个月内腹部CT和12个月内胸部CT。
- 共4438人参加肺癌筛查,4309人(97%)符合腹部NCCT条件,4019人(93%)接受腹部NCCT。
- 进行了6个月随访。
主要发现
- 2586名(64%)参与者腹部NCCT正常,787名(20%)需要腹部NCCT影像复核但无需进一步处理,611名(15%)需要进一步评估(检查 and/or 门诊)。
- 211名(5.3%)参与者发现新的严重病变,包括25名(0.62%)肾脏肿块/复杂囊肿,其中10名(0.25%)经组织学确诊肾癌;10名(0.25%)其他癌症;60名(1.5%)腹主动脉瘤(AAA)。
- 25名(0.62%)参与者接受了治愈性意图治疗。
- 1017名(25%)参与者发现非严重病变,最常见为良性肾囊肿(727名[18%]),仅259名(6.4%)非严重病变需要进一步检查。
- 发现一例严重腹部病变需筛查人数为18;发现一例疑似肾脏病变需筛查人数为93;发现一例组织学确诊肾癌需筛查人数为402。
局限性
- 该队列的局限性为固定年龄范围和均为既往肺癌筛查参加者。
- 现在应评估长期结局和成本效益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: The Yorkshire Kidney Screening Trial (YKST) assessed the feasibility of adding abdominal noncontrast computed tomography (NCCT) to lung cancer screening to screen for kidney cancer and other abdominal pathology. METHODS: A prospective diagnostic study offered abdominal NCCT to 55-80-yr-old ever-smokers attending a UK randomised lung cancer screening trial (May 2021 to October 2022). The exclusion criteria were dementia, frailty, previous kidney/lung cancer, and computed tomography (CT) of the abdomen and thorax within previous 6 and 12 mo, respectively. Six-month follow-up was undertaken. KEY FINDINGS AND LIMITATIONS: A total of 4438 people attended lung screening, of whom 4309 (97%) were eligible for and 4019 (93%) accepted abdominal NCCT. Only 3.9% respondents regretted participating. The additional time to conduct the YKST processes was 13.3 min. Of the participants, 2586 (64%) had a normal abdominal NCCT, whilst 787 (20%) required an abdominal NCCT imaging review but no further action and 611 (15%) required further evaluation (investigations and/or clinic). Of the participants, 211 (5.3%) had a new serious finding, including 25 (0.62%) with a renal mass/complex cyst, of whom ten (0.25%) had histologically proven kidney cancer; ten (0.25%) with other cancers; and 60 (1.5%) with abdominal aortic aneurysms (AAAs). Twenty-five (0.62%) participants had treatment with curative intent. Of the participants, 1017 (25%) had nonserious findings, most commonly benign renal cysts (727 [18%]), whereas only 259 (6.4%) had nonserious findings requiring further tests. The number needed to screen to detect one serious abdominal finding was 18; it was 93 to detect one suspicious renal lesion and 402 to detect one histologically confirmed renal cancer. Limitations of the cohort were fixed age range and being prior lung cancer screening attendees. CONCLUSIONS AND CLINICAL IMPLICATIONS: In this first prospective risk-stratified screening study of abdominal NCCT offered alongside CT thorax, uptake and participant satisfaction were high. The prevalence of serious findings, cancers, and AAAs, is in the range of established screening programmes such as bowel cancer. Longer-term outcomes and cost effectiveness should now be evaluated.
引用
- Stewart GD, Godoy A, Farquhar F, et al. Abdominal Noncontrast Computed Tomography Scanning to Screen for Kidney Cancer and Other Abdominal Pathology Within Community-based Computed Tomography Screening for Lung Cancer: Results of the Yorkshire Kidney Screening Trial. Eur Urol. 2024. PMID: 39271419. doi:10.1016/j.eururo.2024.08.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。